Harumi Iida

4.0k total citations · 3 hit papers
33 papers, 3.5k citations indexed

About

Harumi Iida is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Harumi Iida has authored 33 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Harumi Iida's work include Cancer Treatment and Pharmacology (9 papers), Cancer therapeutics and mechanisms (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Harumi Iida is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Cancer therapeutics and mechanisms (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Harumi Iida collaborates with scholars based in Japan, United States and Canada. Harumi Iida's co-authors include Takashi Tsuruo, Shigeru Tsukagoshi, Yoshio Sakurai, Makiko Nojiri, Hironori Kawabata, Takao Yamori, Tomoko Oh‐hara, Zenji Sato, Shigenobu Okuda and Shigeo Iwasaki and has published in prestigious journals such as International Journal of Cancer, Biochemical Pharmacology and Cancer Letters.

In The Last Decade

Harumi Iida

33 papers receiving 3.3k citations

Hit Papers

Overcoming of vincristine resistance in P388 leukemia in ... 1981 2026 1996 2011 1981 1982 1983 400 800 1.2k

Peers

Harumi Iida
Ursula A. Germann United States
Michael M. Gottesman United States
Ahmad R. Safa United States
Marilyn M. Cornwell United States
Peter Charlton United Kingdom
Janice E. Chin United States
William T. Beck United States
L. Austin Doyle United States
Harumi Iida
Citations per year, relative to Harumi Iida Harumi Iida (= 1×) peers Shigeru Tsukagoshi

Countries citing papers authored by Harumi Iida

Since Specialization
Citations

This map shows the geographic impact of Harumi Iida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harumi Iida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harumi Iida more than expected).

Fields of papers citing papers by Harumi Iida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harumi Iida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harumi Iida. The network helps show where Harumi Iida may publish in the future.

Co-authorship network of co-authors of Harumi Iida

This figure shows the co-authorship network connecting the top 25 collaborators of Harumi Iida. A scholar is included among the top collaborators of Harumi Iida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harumi Iida. Harumi Iida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kei, Junichi, et al.. (1993). [A case of pulmonary solitary metastasis of renal cell carcinoma nine years after radical nephrectomy].. PubMed. 41(6). 1105–9. 1 indexed citations
2.
Yamori, Takao, Harumi Iida, Shigeru Tsukagoshi, & Takashi Tsuruo. (1988). Growth stimulating activity of lung extract on lung-colonizing colon 26 clones and its partial characterization. Clinical & Experimental Metastasis. 6(2). 131–139. 27 indexed citations
3.
Tsuruo, Takashi, Tomoko Oh‐hara, Harumi Iida, et al.. (1986). Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines.. PubMed. 46(1). 381–5. 100 indexed citations
4.
Tsuruo, Takashi & Harumi Iida. (1986). Effects of cytochalasins and colchicine on the accumulation and retention of daunomycin and vincristine in drug resistant tumor cells. Biochemical Pharmacology. 35(7). 1087–1090. 19 indexed citations
5.
Tsuruo, Takashi, Harumi Iida, Fusao Makishima, et al.. (1985). Inhibition of spontaneous and experimental tumor metastasis by the calcium antagonist verapamil. Cancer Chemotherapy and Pharmacology. 14(1). 30–33. 35 indexed citations
6.
Tsuruo, Takashi, Harumi Iida, Hironori Kawabata, Shigeru Tsukagoshi, & Yoshio Sakurai. (1984). High calcium content of pleiotropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells.. PubMed. 44(11). 5095–9. 53 indexed citations
7.
Tsuruo, Takashi, Takao Yamori, Hironori Kawabata, et al.. (1984). Spontaneous metastasis of highly metastatic variants of mouse tumors and the effect of drugs on the metastasis.. PubMed. 75(6). 557–63. 11 indexed citations
8.
Tsuruo, Takashi, Harumi Iida, Saburo Sone, et al.. (1984). Establishment of human KB cells resistant to 1-beta-D-arabinofuranosylcytosine, and mechanisms of cellular resistance in isolated clones.. PubMed. 75(8). 690–8. 2 indexed citations
9.
Tsuruo, Takashi, Harumi Iida, Shigeru Tsukagoshi, & Yoshio Sakurai. (1983). Vincristine-resistant P388 leukemia cells contain a large amount of calcium.. PubMed. 74(5). 619–21. 5 indexed citations
10.
Tsuruo, Takashi, Harumi Iida, Makiko Nojiri, Shigeru Tsukagoshi, & Yoshio Sakurai. (1983). Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine.. Journal of Pharmacobio-Dynamics. 6(2). 145–147. 36 indexed citations
11.
Tsuruo, Takashi, Harumi Iida, Shigeru Tsukagoshi, & Yoshio Sakurai. (1983). Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.. PubMed. 43(5). 2267–72. 221 indexed citations
12.
Tsuruo, Takashi, et al.. (1983). Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug.. PubMed. 43(2). 808–13. 100 indexed citations
13.
Tsuruo, Takashi, et al.. (1983). Establishment and properties of vincristine-resistant human myelogenous leukemia K562.. PubMed. 74(5). 751–8. 39 indexed citations
14.
Tsuruo, Takashi, et al.. (1982). Enzyme catalyzation of the deacylation of N4-acyl derivatives of 1-beta-D-arabinofuranosylcytosine in the mouse liver microsome.. PubMed. 42(6). 2250–4. 8 indexed citations
15.
Tsuruo, Takashi, Harumi Iida, Shigeru Tsukagoshi, & Yoshio Sakurai. (1981). Enhancement of vinblastine-induced cytotoxicity by lysolecithin and phosphatidylinositol. Cancer Letters. 13(2). 133–137. 6 indexed citations
16.
Tsuruo, Takashi, et al.. (1981). Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice.. The Journal of Antibiotics. 34(9). 1206–1209. 25 indexed citations
17.
Tsuruo, Takashi, Harumi Iida, Shigeru Tsukagoshi, & Yoshio Sakurai. (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.. PubMed. 41(5). 1967–72. 1299 indexed citations breakdown →
18.
Tsuruo, Takashi, Harumi Iida, Shigeru Tsukagoshi, & Yoshio Sakurai. (1981). Prevention of vinblastine-induced cytotoxicity by ruthenium red. Biochemical Pharmacology. 30(3). 213–216. 13 indexed citations
19.
Tsuruo, Takashi, Harumi Iida, Shigeru Tsukagoshi, & Yoshio Sakurai. (1980). Suppression of friend leukemia virus by bacillus calmette‐guérin and a streptococcal preparation, OK‐432. International Journal of Cancer. 25(1). 131–136. 3 indexed citations
20.
Tsuruo, Takashi, Harumi Iida, Shigeru Tsukagoshi, & Yoshio Sakurai. (1979). Comparison of cytotoxic effect and cellular uptake of 1-beta-D-arabinofuranosylcytosine and its N4-acyl derivatives, using cultured KB cells.. PubMed. 39(3). 1063–70. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026